Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Blood Transfusion × Classical hematology × Clear all

Phase

Phase 3 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Classical hematology 1

Conditions

Neoplasms 1 Anemia 1

Interventions

Cyclophosphamide 53 Busulfan 42 fludarabine phosphate 40 Cyclosporine 30 Whole-Body Irradiation 27 Mycophenolic Acid 27 fludarabine 25 Peripheral Blood Stem Cell Transplantation 24 Tacrolimus 23 Methotrexate 23 Melphalan 23 Antilymphocyte Serum 23 Darbepoetin alfa 19 Filgrastim 18 Cytarabine 18 Cord Blood Stem Cell Transplantation 16 Radiotherapy 15 Epoetin Alfa 15 Granulocyte Colony-Stimulating Factor 13 Methylprednisolone 11 thymoglobulin 9 Etoposide 9 Alemtuzumab 9 eltrombopag 7 Thiotepa 7 Stem Cell Transplantation 7 Rituximab 6 olaparib 5 hetrombopag 5 Hematopoietic Stem Cell Transplantation 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01116479 2014-11-05

HaemOPtimal

Rigshospitalet, Denmark

Phase 2 Terminated

Classical hematology

Anemia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡